Derived from malignant ascites of a chemonaive ovarian cancer patient
Gender:
Female
Primary citation:
Provencher et al. 2000. In Vitro Cell Dev Biol Anim. (36): 357–361. PMID:10949993.
Alternate name:
OV-90
Product description:
Tumourigenic epithelial ovarian cancer cell line derived from malignant ascites of a patient never exposed to chemotherapy or radiation therapy. Cell line retains characteristics of the original epithelial ovarian cancers from which it was derived.
Gender:
Female
CRISPR:
No
Receptors of note:
No
References:
Raspaglio et al. 2023. Cancers (Basel). 18,15(8):2361. PMID: 37190289
Yee et al. 2022. Front Bioeng Biotechnol. 10,10:836984. PMID: 35223797
Brodeur et al. 2021. Sci Rep. 14,11(1):18183. PMID: 34521878
Buttarelli et al. 2022. J Exp Clin Cancer Res. 4,41(1):50. PMID: 35120576
Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.
